These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31010856)

  • 21. Combination therapy with ampicillin and daptomycin for treatment of Enterococcus faecalis endocarditis.
    Sierra-Hoffman M; Iznaola O; Goodwin M; Mohr J
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6064. PubMed ID: 22964255
    [No Abstract]   [Full Text] [Related]  

  • 22. Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates.
    Cusumano JA; Khan R; Shah Z; Philogene C; Harrichand A; Huang V
    Microbiol Spectr; 2022 Aug; 10(4):e0062122. PubMed ID: 35703558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemia.
    Foo H; Chater M; Maley M; van Hal SJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2252-7. PubMed ID: 24744303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study.
    Falcone M; Tiseo G; Dentali F; Foglia E; Campanini M; Menichetti F; Mazzone A;
    J Glob Antimicrob Resist; 2019 Sep; 18():139-144. PubMed ID: 30825701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of vancomycin-resistant enterococcal endocarditis.
    Brink AJ; van den Ende J; Routier RJ; Devenish L
    S Afr Med J; 2000 Nov; 90(11):1113-5. PubMed ID: 11196031
    [No Abstract]   [Full Text] [Related]  

  • 26. High Prevalence of the
    Costa LBD; Corá LF; Correa FEL; Gabrielli LC; de Oliveira MR; Conceição N; Oliveira AG
    Microb Drug Resist; 2019 Nov; 25(9):1275-1281. PubMed ID: 31361553
    [No Abstract]   [Full Text] [Related]  

  • 27. Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis.
    Gil-Navarro MV; Lopez-Cortes LE; Luque-Marquez R; Galvez-Acebal J; de Alarcon-Gonzalez A
    J Clin Pharm Ther; 2018 Apr; 43(2):220-223. PubMed ID: 29030859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina.
    Predari SC; Gutiérrez MA; Ribas C; Molinari GS; Santoianni JE
    Rev Argent Microbiol; 1991; 23(2):67-78. PubMed ID: 1815269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.
    Gavaldà J; Len O; Miró JM; Muñoz P; Montejo M; Alarcón A; de la Torre-Cisneros J; Peña C; Martínez-Lacasa X; Sarria C; Bou G; Aguado JM; Navas E; Romeu J; Marco F; Torres C; Tornos P; Planes A; Falcó V; Almirante B; Pahissa A
    Ann Intern Med; 2007 Apr; 146(8):574-9. PubMed ID: 17438316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of penicillin-gentamicin and dual beta-lactam therapies in Enterococcus faecalis infective endocarditis.
    Freeman L; Milkovits A; McDaniel L; Everson N
    Int J Antimicrob Agents; 2022 Mar; 59(3):106522. PubMed ID: 35038556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Australian Enterococcal Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Pearson JC; Daly DA; Le TT; Robinson JO; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E320-6. PubMed ID: 25631594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.
    Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A
    J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study.
    Billington EO; Phang SH; Gregson DB; Pitout JD; Ross T; Church DL; Laupland KB; Parkins MD
    Int J Infect Dis; 2014 Sep; 26():76-82. PubMed ID: 24813873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.
    Westbrook KJ; Chilambi GS; Stellfox ME; Nordstrom HR; Li Y; Iovleva A; Shah NH; Jones CE; Kline EG; Squires KM; Miller WR; Tran TT; Arias CA; Doi Y; Shields RK; Van Tyne D
    J Antimicrob Chemother; 2024 Apr; 79(4):801-809. PubMed ID: 38334390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates.
    Metzidie E; Manolis EN; Pournaras S; Sofianou D; Tsakris A
    J Antimicrob Chemother; 2006 Jan; 57(1):158-60. PubMed ID: 16308417
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis.
    El Rafei A; DeSimone DC; Narichania AD; Sohail MR; Vikram HR; Li Z; Steckelberg JM; Wilson WR; Baddour LM
    J Infect; 2018 Nov; 77(5):398-404. PubMed ID: 29969596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of
    Kim D; Yoon EJ; Hong JS; Lee H; Shin KS; Shin JH; Kim YR; Kim HS; Kim YA; Uh Y; Shin JH; Park YS; Jeong SH
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.
    Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM;
    Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method.
    Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F
    J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.